Repaglinide
NDC 71335-2554, Repaglinide, tablet, from Bryant Ranch Prepack.
- Product NDC
- 71335-2554
- Status
- Listed
- Labeler
- Bryant Ranch Prepack
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207209
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71335-2554 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REPAGLINIDE.5 mg/1
Pharmacologic classes
Glinide [EPC]; Potassium Channel Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71335-2554-1 | 71335255401 | 30 TABLET in 1 BOTTLE (71335-2554-1) |
| 71335-2554-2 | 71335255402 | 90 TABLET in 1 BOTTLE (71335-2554-2) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9f2006d9-e0c0-4cc4-b2c9-84b7d9f77173
Use it
Look up 71335-2554 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71335-2554 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71335-2554. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.